ANVS - Company ID 0001477845
Annovis Bio, Inc. trades as ANVS. This page tracks Annovis Bio, Inc. through 297 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-21 |
| Major company event | 8-K | 2026-05-20 |
| Prospectus supplement | 424B5 | 2026-05-20 |
| Prospectus supplement | 424B5 | 2026-05-19 |
| Quarterly report | 10-Q | 2026-05-15 |
| Major company event | 8-K | 2026-05-15 |
| Proxy materials | DEFA14A | 2026-04-30 |
| Proxy statement | DEF 14A | 2026-04-30 |
The largest companies sharing Annovis Bio, Inc.'s SEC industry classification (pharmaceutical preparations).